Appili Therapeutics Inc. (APLI.TO)

CAD 0.04

(-12.5%)

Total Debt Summary of Appili Therapeutics Inc.

Appili Therapeutics Inc.'s latest annual total debt in 2023 was 8.18 Million CAD , up 6.78% from previous year.
Appili Therapeutics Inc.'s latest quarterly total debt in 2024 Q1 was 10.05 Million CAD , up 22.81% from previous quarter.
Appili Therapeutics Inc. reported annual total debt of 7.66 Million CAD in 2022, up 53.96% from previous year.
Appili Therapeutics Inc. reported annual total debt of 4.97 Million CAD in 2021, up 382.15% from previous year.
Appili Therapeutics Inc. reported quarterly total debt of 8.18 Million CAD for 2023 Q4, up 2.16% from previous quarter.
Appili Therapeutics Inc. reported quarterly total debt of 8 Million CAD for 2023 Q2, up 4.1% from previous quarter.

Annual Total Debt Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Total Debt of Appili Therapeutics Inc. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	8.18 Million CAD	6.78%
2022	7.66 Million CAD	53.96%
2021	4.97 Million CAD	382.15%
2020	1.03 Million CAD	2.75%
2019	1 Million CAD	-10.16%
2018	1.11 Million CAD	0.65%
2017	1.11 Million CAD	158.47%
2016	430 Thousand CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	10.05 Million CAD	22.81%
2023 Q4	8.18 Million CAD	2.16%
2023 Q2	8 Million CAD	4.1%
2023 Q1	7.68 Million CAD	0.29%
2023 Q3	8.01 Million CAD	0.12%
2023 FY	8.18 Million CAD	6.78%
2022 FY	7.66 Million CAD	53.96%
2022 Q2	5.41 Million CAD	3.45%
2022 Q3	5.44 Million CAD	0.5%
2022 Q4	7.66 Million CAD	40.87%
2022 Q1	5.23 Million CAD	5.12%
2021 Q1	1.01 Million CAD	-1.69%
2021 FY	4.97 Million CAD	382.15%
2021 Q4	4.97 Million CAD	65.85%
2021 Q3	3 Million CAD	-21.03%
2021 Q2	3.8 Million CAD	274.45%
2020 Q4	1.03 Million CAD	-0.59%
2020 Q3	1.03 Million CAD	2.5%
2020 Q1	1 Million CAD	-0.09%
2020 FY	1.03 Million CAD	2.75%
2020 Q2	1.01 Million CAD	0.93%
2019 Q2	1 Million CAD	0.68%
2019 Q1	1 Million CAD	-10.55%
2019 FY	1 Million CAD	-10.16%
2019 Q4	1 Million CAD	-0.66%
2019 Q3	1.01 Million CAD	0.43%
2018 Q4	1.11 Million CAD	15.52%
2018 FY	1.11 Million CAD	0.65%
2018 Q3	968.3 Thousand CAD	0.0%
2018 Q1	- CAD	-100.0%
2017 Q4	1.11 Million CAD	0.0%
2017 FY	1.11 Million CAD	158.47%
2016 FY	430 Thousand CAD	0.0%

Peer Total Debt Comparison of Appili Therapeutics Inc.

Name	Total Debt	Total Debt Difference
Eupraxia Pharmaceuticals Inc.	13.78 Million CAD	40.612%
Helix BioPharma Corp.	- CAD	-Infinity%
Microbix Biosystems Inc.	6.64 Million CAD	-23.167%
Medicenna Therapeutics Corp.	- CAD	-Infinity%
Satellos Bioscience Inc.	- CAD	-Infinity%
Oncolytics Biotech Inc.	423 Thousand CAD	-1834.954%
Sernova Corp.	136.12 Thousand CAD	-5912.838%